HRMY Max Pain
The max pain for Harmony Biosciences Holdings Inc (HRMY) options expiring Feb 19, 2027 (96 DTE) is $17.50.
HRMY Max Pain by Expiry
The Max Pain for all expiration dates of HRMY.
| Expiration | Max Pain | Max Pain vs Current Price |
|---|---|---|
| Nov 20, 2026 5 DTE monthly | 37.50 | 4.75 (14.50%) |
| Dec 18, 2026 33 DTE monthly | 37.50 | 4.75 (14.50%) |
| Jan 15, 2027 61 DTE monthly | 40.00 | 7.25 (22.14%) |
| Feb 19, 2027 96 DTE monthly | 17.50 | -15.25 (-46.56%) |
| Apr 16, 2027 152 DTE monthly | 35.00 | 2.25 (6.87%) |
HRMY Max Pain FAQ
What is max pain?
Max pain is the price where the total value of all open calls and puts would be lowest at expiration, so option buyers as a group would lose the most. Some traders watch it as a level the stock may drift toward near expiration, because option sellers, often market makers, hedge their positions in ways that can pull the price toward heavily traded strikes. It is a theory, not a guarantee.
What is HRMY max pain this week?
As of the Nov 13, 2026 close, max pain for Harmony Biosciences options expiring Feb 19, 2027 is $17.50. The chart above shows the exact max pain for each expiration date.
Does HRMY trade above or below its max pain?
Harmony Biosciences closed above its near-term max pain on 5 of the last 20 trading days. On Nov 13, 2026 it closed at $33.76, 10.0% below max pain of $37.50.
How has HRMY max pain changed recently?
Over the last 20 trading days, near-term max pain for Harmony Biosciences ranged from $37.50 to $40.85. It went from $40.85 on Oct 19, 2026 to $37.50 on Nov 13, 2026. See the HRMY max pain history for a longer view.
What is Harmony Biosciences Holdings Inc?
Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs.